NASDAQ:TVTX

Travere Therapeutics Stock Forecast

etoro logo Buy TVTX
*Your capital is at risk
$56.71
+1.43 (+2.59%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of TVTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TVTX to Watchlist?
Some Reasons Why To Add TVTX:
  • +252.0% price growth over the last year
  • High gross margin of 94.0%
  • Low bankruptcy risk (Altman Z-Score: 4.42)
PDF

Travere Therapeutics, Inc. stock price ended at $56.71 on Friday, after gaining 2.59%
(Updated on Jul 17, 2026)

Buy or Hold candidate since Apr 15, 2026 Gain 38.49%

The Travere Therapeutics, Inc. stock price gained 2.59% on the last trading day (Friday, 17th Jul 2026), rising from $55.28 to $56.71. During the last trading day the stock fluctuated 8.11% from a day low at $53.00 to a day high of $57.30. The price has risen in 6 of the last 10 days but is still down by -0.37% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 28 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $82.13 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 47.96% during the next 3 months and, with a 90% probability hold a price between $79.20 and $94.91 at the end of this 3-month period.

TVTX Signals & Forecast

The Travere Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $56.73. On a fall, the stock will find some support from the long-term average at approximately $53.31. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 25, 2026, and so far it has fallen -3.93%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

Travere Therapeutics, Inc. finds support from accumulated volume at $55.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $4.30 (8.11%) between high and low. For the last week, the stock has had daily average volatility of 4.64%.

Our recommended stop-loss: $54.11 (-4.59%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 15 days ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Travere Therapeutics, Inc. to open at $55.67, and during the day (based on 14 day Average True Range), to move between $55.54 and $57.88, which gives a possible trading interval of +/-$2.35 (+/-4.23%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $57.69 (1.73%) than the support at $55.15 (2.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Travere Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term.

Current score: 3.943 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $55.67 ( 1.83%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TVTX Performance

Trading levels for TVTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 59.97 5.75%
R2 58.33 2.85%
R1 57.31 1.06%
Price 56.71
S1 54.03 -4.73%
S2 53.01 -6.52%
S3 51.37 -9.42%

Accumulated Volume Support & Resistance Levels

Level Price
R3 59.03 4.09%
R2 58.85 3.77%
R1 57.69 1.73%
Price 56.71
S1 55.15 -2.75%
S2 47.76 -15.78%
S3 42.66 -24.78%

FAQ

What is the symbol for Travere Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Travere Therapeutics, Inc. is TVTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Travere Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term.

How to buy Travere Therapeutics, Inc. Stock?
Travere Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.

What's the current price of Travere Therapeutics, Inc. Stock?
As of the end of day on the Jul 17, 2026, the price of an Travere Therapeutics, Inc. (TVTX) share was $56.71.

What is the 52-week high and low for Travere Therapeutics, Inc. Stock?
The 52-week high for Travere Therapeutics, Inc. Stock is $60.10 and the 52-week low is $15.05.

What is the market capitalization of Travere Therapeutics, Inc. Stock?
As of the Jul 17, 2026, the market capitalization of Travere Therapeutics, Inc. is 5.274B.

When is the next earnings date for Travere Therapeutics, Inc.?
The upcoming earnings date for Travere Therapeutics, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT TRAVERE THERAPEUTICS, INC.
Travere Therapeutics
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE